| Identification | Back Directory | [Name]
4-(N-Boc-amino)-1,6-heptanedioic acid | [CAS]
848242-88-6 | [Synonyms]
4-(N-Boc-amino)-1,6-heptanedioic acid
4-((tert-butoxycarbonyl)amino)heptanedioicacid
Heptanedioic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]- | [Molecular Formula]
C12H21NO6 | [MDL Number]
MFCD23726631 | [MOL File]
848242-88-6.mol | [Molecular Weight]
275.3 |
| Hazard Information | Back Directory | [Description]
4-(N-Boc-amino)-1,6-heptanedioic acid is a branched compound. It can conjugate with primary amino groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. Boc can be removed under acidic condition. | [Uses]
4-(N-Boc-amino)-1,6-heptanedioic Acid (cas# 848242-88-6) can be used in the preparation of Trastuzumab-linked TLR-agonist-containing conjugates for targeted treatment of cancer. It is also used in the preparation of insulin analog dimers, and composition containing them or an insulin receptor partial agonist and a GLP-1 analog for treating diabetes and related disorders. | [IC 50]
Alkyl/ether |
|
| Company Name: |
Nextpeptide Inc
|
| Telephone: |
+86-0571-81612335 +8613336028439 |
| Website: |
http://www.nextpeptide.com/ |
|